Department of Statistics Banner Image

Publications

Export 11 results:
Filters: Author is Yu, C. Y.  [Clear All Filters]
2005
Rovin BH, Tang Y, Sun J, Nagaraja HN, Hackshaw KV, Gray L, Ladson-Wofford SE, Birmingham DJ, Yu CY, Spetie DN et al..  2005.  Clinical Significance Of Fever In The SLE Patient Receiving Steroid Therapy. Kidney International. 68(2):747-759.
Rovin BH, Song H, Hebert LA, Nadasdy T, Nadasdy G, Birmingham DJ, Yu CY, Nagaraja HN.  2005.  Plasma, urine, and renal expression of adiponectin in human systemic lupus erythematosus. Kidney International. 68(4):1825-1833.
Rovin BH, Song H, Birmingham DJ, Hebert LA, Yu CY, Nagaraja HN.  2005.  Urine Chemokines as Biomarkers of Human Systemic Lupus Erythematosus Activity. Journal of the American Society of Nephrology. 16(2):467-473.
2006
Birmingham DJ, Nagaraja HN, Rovin BH, Spetie L, Zhao Y, Li X, Hackshaw KV, Yu CY, Malarkey WB, Hebert LA.  2006.  Fluctuation in self-perceived stress increases risk of flare in SLE nephritis patients carrying the 5-HT1A -1019G allele. Arthritis & Rheumatism. 54(10):3291-3299.
Wu YL, Higgins GC, Rennebohm RM, Chung EK, Yang Y, Zhou B, Nagaraja HN, Birmingham DJ, Rovin BH, Hebert LA et al..  2006.  Three distinct profiles of serum complement C4 proteins in pediatric systemic lupus erythematosus (SLE) patients: tight associations of complement C4 and C3 protein levels in SLE but not in healthy subjects. Advances in experimental medicine and biology. 586:227-247.
Birmingham DJ, Gavit KF, McCarty SM, Yu CY, Rovin BH, Nagaraja HN, Hebert LA.  2006.  Consumption of erythrocyte CR1 (CD35) is associated with protection against systemic lupus erythematosus renal flare. Clinical and Experimental Immunology. 143(2):274-80.
2007
Rovin DH, Birmingham DJ, Nagaraja HN, Yu CY, Hebert LA.  2007.  Biomarker Discovery in Human SLE Nephritis. Bulletin of the NYU Hospital for Joint Diseases. 65(3):187-193.
Wang L, Lin S, Rammoham K, Liu Z, Liu J-Q, Liu R-J, Guinther N, Lima J, Zhou Q, Wang T et al..  2007.  A Destabilizing Di-nucleotide Deletion in 3'-Untranslated Region of CD24 mRNA Confers Protection against both Systemic and Organ-specific Autoimmune Diseases. PLoS Genetics. 3:e49.
Yang Y, Chung EK, Wu YL, Savelli SL, Nagaraja HN, Zhou B, Hebert M, Jones KN, Shu Y, Kitzmiller K et al..  2007.  Gene Copy Number Variation and Associated Polymorphisms of Complement Component C4 in Human Systemic Lupus Erythematosus (SLE): Low Copy Number Is a Risk Factor for, High Copy Number Is a Protective Factor against, European American SLE Disease Susceptibi. American Journal of Human Genetics. 80(6):1037-1054.
Wu YL, Savelli SL, Yang Y, Zhou B, Rovin B, Birmingham DH, Nagaraja HN, Hebert LA, Yu CY.  2007.  Sensitive and Specific Real-Time PCR Assays to Accurately Determine Gene Copy Number Variations (GCNVs) of Human Complement C4A, C4B, C4-Long, C4-Short and RCCX Modules: Elucidation of C4 GCNVs in 50 Consanguineous Subjects with Defined HLA Genotypes. Journal of Immunology. 179:3012-3025.
Birmingham DJ, Irshaid F, Gavit KF, Nagaraja HN, Yu CY, Rovin BH, Hebert LA.  2007.  Spot urine protein/creatinine ratio is an unreliable estimate of 24-hr proteinuria in most SLE nephritis flares. Kidney International. 72:865-870.